Using the therapy and enhancement distinction in law and policy
In a first major study, the UK’s Royal Society found that 76% of people in the UK are in favour of therapeutic germline genomic editing to correct genetic diseases in human embryos, but found there was little appetite for germline genomic editing for non-therapeutic purposes. Assuming the UK and oth...
| Main Author: | |
|---|---|
| Format: | Electronic Article |
| Language: | English |
| Check availability: | HBZ Gateway |
| Journals Online & Print: | Drawer...
|
| Fernleihe: | Fernleihe für die Fachinformationsdienste |
| Published: |
Wiley-Blackwell
[2020]
|
| In: |
Bioethics
Year: 2020, Volume: 34, Issue: 1, Pages: 70-80 |
| RelBib Classification: | NCH Medical ethics XA Law ZC Politics in general |
| Further subjects: | B
Policy
B Therapy B Law B Allen Buchanan B John Harris B Regulation B germline genome editing B Enhancement |
| Online Access: |
Volltext (Verlag) Volltext (doi) |